LOS GATOS, Calif., Aug. 4, 2026 /PRNewswire/ -- Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the second quarter ended June 30, 2026.

Recent Company Highlights

Announced a new approach to GaN-on-Silicon that addresses a key performance barrier for RF applications
Continued strong progress with GAA customers
Growing interest from DRAM and flash memory providers

Management Commentary

"This quarter Atomera made excellent progress with customer engagements across our key target markets, in particular the advanced logic and memory segments where AI is creating the need for further performance improvements," said Scott Bibaud, president and CEO of Atomera. "In the past, RF designers have avoided using GaN for high volume applications because of the high cost and complexity of working with GaN on Silicon Carbide. Our breakthrough results with RF GaN on silicon have the potential to enable an entirely new class of RF devices which can now take advantage of the performance improvements GaN provides with the low cost of silicon substrates."

Financial Results

The Company incurred a net loss of ($6.3) million, or ($0.17) per basic and diluted share in the second quarter of 2026, compared to a net loss of ($5.0) million, or ($0.17) per basic and diluted share, for the second quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the second quarter of 2026 was a loss of ($5.0) million compared to an adjusted EBITDA loss of ($4.0) million in the second quarter of 2025.

The Company had $38.4 million in cash, cash equivalents, and short-term investment as of June 30, 2026 compared to $19.2 million of cash and cash equivalents as of December 31, 2025.

The total number of shares outstanding was 39.0 million as of June 30, 2026.

Second Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, Aug. 4, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST^®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow –

Atomera Incorporated Condensed Balance Sheets (in thousands, except per share data)

	June 30,		December 31,
	2026		2025
		(Unaudited)
ASSETS

Current assets:
Cash and cash equivalents	$	15,146	$	19,210
Short-term investments		23,206		–
Interest receivable		58		54
Prepaid expenses and other current assets		542		338
Total current assets		38,952		19,602

Property and equipment, net		59		60
Security deposit		14		14
Operating lease right-of-use asset		1,128		884
Financing lease right-of-use-asset		70		533

Total assets	$	40,223	$	21,093

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Accounts payable	$	569	$	608
Accrued expenses		297		168
Accrued payroll related expenses		1,118		650
Current operating lease liability		304		147
Current financing lease liability		–		420
Deferred Revenue		–		7
Total current liabilities		2,288		2,000

Long-term operating lease liability		860		712

Total liabilities		3,148		2,712

Commitments and contingencies		–		–

Stockholders' equity:		–		–
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock: $0.001 par value, authorized 47,500 shares; 39,024 shares issued and outstanding as of June 30, 2026; and 32,354 shares issued and outstanding as of December 31, 2025		39		32
Additional paid in capital		291,157		260,043
Other comprehensive income (loss)		(18)		–
Accumulated deficit		(254,103)		(241,694)
Total stockholders' equity		37,075		18,381
Total liabilities and stockholders' equity	$	40,223	$	21,093

Atomera Incorporated Condensed Statements of Operations (Unaudited) (in thousands, except per share data)

	Three Months Ended							Six Months Ended
		June 30,		March 31,		June 30,		June 30,
		2026		2026		2025		2026		2025
Revenue		$	158	$	11	$	–	$	169		$	4
Cost of revenue			(26)		(126)		(62)		(152)			(62)
Gross margin			132		(115)		(62)		17			(58)

Operating expenses
Research and development			3,287		3,457		3,004		6,744			6,259
General and administrative			3,167		2,333		2,048		5,500			4,136
Selling and marketing			437		419		141		856			265
Total operating expenses			6,891		6,209		5,193		13,100			10,660

Loss from operations			(6,759)		(6,324)		(5,255)		(13,083)			(10,718)

Other income (expense)
Interest income			172		197		234		369			504
Accretion income			178		57		–		235			6
Interest expense			(1)		(4)		(18)		(5)			(39)
Other income, net			74		1		72		75			71
Total other income (expense), net			423		251		288		674			542

Net loss		$	(6,336)	$	(6,073)	$	(4,967)	$	(12,409)		$	(10,176)

Net loss per common share, basic and diluted		$	(0.17)	$	(0.17)	$	(0.17)	$	(0.34)		$	(0.34)

Weighted average number of common shares outstanding, basic and diluted			38,647		35,256		30,397		36,961			30,321

Atomera Incorporated Reconciliation to Non-GAAP EBITDA (Unaudited)

	Three Months Ended							Six Months Ended
		June 30,		March 31,		June 30,		June 30,
		2026		2026		2025		2026			2025
Net loss (GAAP)		$	(6,336)	$	(6,073)	$	(4,967)	$	(12,409)	$		(10,176)
Depreciation and amortization			6		9		12		15			24
Stock-based compensation			1,741		1,406		1,278		3,147			2,287
Interest income			(172)		(197)		(234)		(369)			(504)
Accretion income			(178)		(57)		–		(235)			(6)
Interest expense			1		4		18		5			39
Other income, net			(74)		(1)		(72)		(75)			(71)
Net loss non-GAAP EBITDA		$	(5,012)	$	(4,909)	$	(3,965)	$	(9,921)	$		(8,407)

View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-provides-second-quarter-2026-results-302842843.html

SOURCE Atomera Incorporated